MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Effect of Rehabilitation on Freezing of Gait in Parkinson’s disease: A meta-analysis

    M. Gilat, P. Ginis, N. D'Cruz, A. Nieuwboer (Leuven, Belgium)

    Objective: To summarize the effect of rehabilitation-based interventions on freezing of gait (FOG) in Parkinson’s disease (PD). Background: Rehabilitation is emerging as an important adjunct…
  • 2019 International Congress

    Effectiveness on the balance and the walking of a program of home-rehabilitation by digital support versus paper book on Parkinson’s patients: a randomized controlled trial.

    M. Moreau, B. Fraudet, P. Gallien, B. Nicolas, E. Leblong (Rennes, France)

    Objective: The objective is to evaluate the effects on the balance and the walk of a program of 3 months of home-rehabilitation guided by digital…
  • 2019 International Congress

    SWALLOWING VIDEOENDOSCOPY IN PATIENTS WITH PARKINSON’S DISEASE WITH DEEP BRAIN STIMULATION

    T. Alves, N. Oliveira, G. Diaféria, M. Palumbo, MG. Ghilardi, E. Fonoff, M. Padovani (São Paulo, Brazil)

    Objective: Objective: to characterize swallowing in patients with DBS, comparing ON and OFF stimulation state. Background: Swallowing dysfunction is a frequent complication of Parkinson’s disease…
  • 2019 International Congress

    Identifying In-Clinic Wearable Sensor Features that Predict Parkinson’s Disease Severity

    A. Dowling, A. Mirelman, J. Hausdorff, M. Sela, O. Assais, N. Giladi, J. Cedarbaum (Cambridge, MA, USA)

    Objective: To identify features from wearable sensors that can predict disease severity as measured by the MDS-UPDRS. Background: Wearable sensors can provide quantitative assessments of…
  • 2019 International Congress

    Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in de-novo diagnosed Parkinson patients

    F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, W. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)

    Objective: To determine the reliability and validity of a novel, comprehensive digital biomarker remote monitoring approach to actively and passively measure motor symptom progression in…
  • 2019 International Congress

    Cerebral cavernous malformations and movement disorders

    M. Polemikos, E. Hermann, J. Krauss (Hannover, Germany)

    Objective: To present the unusual occurrence of movement disorders (MD) secondary to cerebral cavernous malformations (CCM). Background: CCM most frequently become manifest by seizures, focal…
  • 2019 International Congress

    Healthcare Resource Utilization and Costs of Parkinson’s Disease Dementia With Psychosis in the US Medicare Population

    J. Wetmore, H. Yan, M. Irfan, Y. Peng, D. Gilbertson, S. Li, N. Rashid, A. Shim (Minneapolis, MN, USA)

    Objective: To describe healthcare resource use (HCRU) and related costs among Parkinson’s patients with dementia (PDD) and psychosis compared with other dementia types in a…
  • 2019 International Congress

    The trace of substantia nigra hyperechogenicity: a clinical observation

    A. Alonso-Canovas, JL. Sendon-Moreno, G. Garcia-Ribas, N. Monterde-Gonzalez, C. Jara-Laguna, JC. Martinez-Castrillo, J. Masjuan (Madrid, Spain)

    Objective: To present an empirical observation regarding transcranial ultrasound in movement disorders and scalp sebum smear. Background: Transcranial ultrasound (TUS) detects substantia nigra hyperechogenicity (SN+) in…
  • 2019 International Congress

    Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson’s disease is safe and may be advantageous

    F. Baig, L. Mooney, M. Selikhova, M. Rolinski, K. Szewczyk-Krolikowski, N. Collin, A. Whone (Bristol, United Kingdom)

    Objective: We describe a case series of 12 patients requiring administration of levodopa-carbidopa intestinal gel (LCIG) who had their tube placed by  per-oral image guided…
  • 2019 International Congress

    Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson’s disease : a large single-center study

    A-S. Blaise, G. Baille, N. Carrière, D. Devos, K. Dujardin, G. Grolez, A. Kreisler, M. Kyheng, C. Moreau, E. Mutez, D. Seguy, L. Defebvre (Lille, France)

    Objective: To describe adverse events (AEs) associated with levodopa-carbidopa intestinal gel (LCIG) treatment and the main reasons for treatment discontinuation. We also assessed the effectiveness…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 217
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley